Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

FDA approves tirzepatide, Eli Lilly’s new type 2 diabetes drug, and the company shares an estimated price

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Intermittent fasting helps breast cancer survivors limit their CVD risk

A new study published in the Journal of the American College of Cardiology examined how a breast cancer survivor's eating schedule may impact their risk of cardiac events. 

Renal denervation is associated with improved blood pressure (BP) control and a reduced risk of adverse cardiovascular outcomes, according to two late-breaking clinical trials presented at EuroPCR 2022 in Paris. Both clinical trials focused on three-year data related to Medtronic’s Symplicity Spyral Renal Denervation (RDN) System, which was designed to lower BP through the use of a curling catheter that ablates overactive nerves.

Renal denervation improves blood pressure control, lowers risk of adverse cardiovascular outcomes

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

Thumbnail

Arterial stiffness may predict type 2 diabetes risk better than high blood pressure

Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

Thumbnail

A key update: 1 year later, no signs of long-term heart damage among college athletes who had COVID-19

More than 3,500 college athletes with a confirmed COVID-19 diagnosis were included in the new study. The median follow-up period was more than one full year. 

Thumbnail

Mediterranean diet outperforms low-fat diet for cardiovascular disease prevention

“Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention," researchers wrote. 

Engineers have developed and tested a new wearable device capable of monitoring a person’s blood sugar, alcohol and lactate levels all at the same time, detailing their work in Nature Biomedical Engineering

Small wearable device monitors blood sugar, alcohol and lactate levels at the same time

Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.

Displaying 329 - 336 of 1186

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.